Uterin spindle cell mesenchymal neoplazm, NTRK fusion-positive uterine sarcoma

被引：0
|
作者：
Konuk, B. [1 ]
Topal, C. S. [1 ]
机构：
[1] Umraniye EducationTraining Hosp, Umraniye Istanbul, Turkey
来源：
VIRCHOWS ARCHIV | 2022年 / 481卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-09-03
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 50 条
  • [41] Supratentorial ependymoma, ZFTA fusion-positive, with extensive mesenchymal differentiation
    Persons, Jane E.
    Freitas, Leonardo F.
    Eschbacher, Kathryn L.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 84 (01): : 80 - 83
  • [42] Mesenchymal Differentiation in ZFTA Fusion-Positive Ependymoma: A Case Report
    Smith, Heather
    Hamed, Ghiath
    Aldape, Kenneth
    Pratt, Drew
    Pytel, Peter
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (06): : 459 - 459
  • [43] Entrectinib in NTRK fusion-positive (NTRK-fp) breast cancer: Updated data from STARTRK-2
    Lu, J.
    Blakely, C. M.
    Barve, M.
    Chung, C. H.
    Waqar, S. N.
    Hu, X.
    Delord, J-P.
    Krzakowski, M. J.
    Yonemori, K.
    Chen, D. T.
    Klingbiel, D.
    Heinzmann, S.
    Le Tourneau, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S204 - S205
  • [44] Efficacy and safety of entrectinib in patients with locally advanced/metastatic NTRK fusion-positive (NTRK-fp) solid tumours
    Bazhenova, L.
    Liu, S. V.
    Lin, J. J.
    Lu, S.
    Drilon, A.
    Chawla, S. P.
    Fakih, M.
    Krzakowski, M.
    Paz-Ares, L.
    Blakely, C.
    Buchschacher, G. L., Jr.
    Cassier, P.
    Fan, Y.
    Folprecht, G.
    McCallum, S.
    Pitcher, B.
    Chen, D.
    Freund, R.
    Springfeld, C.
    ANNALS OF ONCOLOGY, 2021, 32 : S598 - S599
  • [45] A Case of Isolated Leptomeningeal Progression in a Patient with NTRK Fusion plus Uterine Sarcoma
    Lanman, Tyler
    Hayden, Melanie
    Bui, Nam
    Nagpal, Seema
    NEUROLOGY, 2021, 96 (15)
  • [46] Uterine Sarcoma With EML4::NTRK3 Fusion: A Spectrum of Mesenchymal Neoplasms Harboring Actionable Gene Fusions
    de Castro, Joao Victor Alves
    dos Santos, Pedro Jose Silva
    Mantoan, Henrique
    Baiocchi, Glauco
    Bovolim, Graziele
    Torrezan, Giovana
    Corassa, Marcelo
    do Nascimento, Antonio Geraldo
    De Brot, Marina
    Costa, Felipe D'Almeida
    De Brot, Louise
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (01) : 56 - 60
  • [47] p53 immunohistochemical analysis of fusion-positive uterine sarcomas
    Mohammad, Nissreen
    Stewart, Colin J. R.
    Chiang, Sarah
    Turashvili, Gulisa
    Dickson, Brendan C.
    Ng, Tony L.
    Kobel, Martin
    McCluggage, W. Glenn
    Croce, Sabrina
    Lee, Cheng-Han
    HISTOPATHOLOGY, 2021, 78 (06) : 805 - 813
  • [48] Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors or ROS1-Positive NSCLC with CNS Metastases
    Paz-Ares, Luis
    Dziadziuszko, Rafal
    Drilon, Alexander
    John, Thomas
    Krebs, Matthew
    Demetri, George
    Shaw, Alice T.
    Siena, Salvatore
    Wolf, Juergen
    Farago, Anna F.
    Simmons, Brian
    Pitcher, Bethany
    Huang, Xinhui
    Doebele, Robert
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 235 - 235
  • [49] COST-EFFECTIVENESS ANALYSIS OF ENTRECTINIB FOR TREATMENT NTRK FUSION-POSITIVE TUMORS IN CZECH REPUBLIC
    Dolezel, J.
    Pour, M.
    Motylova, S.
    Novak, J.
    Skalicky, D.
    VALUE IN HEALTH, 2022, 25 (12) : S101 - S101
  • [50] Entrectinib in Patients with ROS1-Positive NSCLC or NTRK Fusion-Positive Solid Tumors with CNS Metastases
    Paz-Ares, L.
    Dziadziuszko, R.
    Drilon, A.
    John, T.
    Krebs, M.
    Demetri, G.
    Shaw, A.
    Siena, S.
    Wolf, J.
    Farago, A.
    Simmons, B.
    Ye, C.
    Huang, X.
    Doebele, R.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S305 - S305
12345